• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Jounce Therapeutics Inc (NQ: JNCE )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, May 3, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open -
    Bid (Size) 1.890 (19)
    Ask (Size) 1.920 (18)
    Prev. Close 1.880
    Today's Range N/A - N/A
    52wk Range N/A - N/A
    Shares Outstanding 51,232,029
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Jounce Therapeutics, Inc. (Nasdaq- JNCE) and Berkshire Grey, Inc. (Nasdaq- BGRY)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Nasdaq Edges Lower; Unity Biotechnology Shares Plummet
    U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading lower on Monday. The Dow traded up 0.91% to 32,530.40 while the NASDAQ fell 0.09% to 11,813.90. The S&P 500, also... 
    Via Benzinga

    Performance

    More News

    Read More
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Gold Drops Over 1%; First Citizens BancShares Shares Spike Higher
    Via Benzinga
    JNCE STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Jounce Therapeutics, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Top 5 Health Care Stocks That May Crash In March
    Via Benzinga
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
    Via Benzinga
    Jounce Therapeutics Says JTX-8064/Pimivalimab Shows Deep, Durable Responses In Pretreated Ovarian Cancer Patients
    Via Benzinga
    S&P 500 Down Over 1%; ThermoGenesis Shares Spike Higher
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Nasdaq Down Over 100 Points; Crude Oil Drops 5%
    Via Benzinga
    Why Is Boxed (BOXD) Stock Down 41% Today?
    Via InvestorPlace
    Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Why Is Inpixon (INPX) Stock Down 34% Today?
    Via InvestorPlace
    Why Jounce Therapeutics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Why Is Jounce Therapeutics (JNCE) Stock Up 37% Today?
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    JOUNCE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Jounce Therapeutics, Inc. - JNCE
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
    Via Benzinga
    Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2023
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.